Harry Cassin
Publisher and Editor
Andy Spalding
Senior Editor
Jessica Tillipman
Senior Editor
Bill Steinman
Senior Editor
Richard L. Cassin
Editor at Large
Elizabeth K. Spahn
Editor Emeritus
Cody Worthington
Contributing Editor
Julie DiMauro
Contributing Editor
Thomas Fox
Contributing Editor
Marc Alain Bohn
Contributing Editor
Bill Waite
Contributing Editor
Shruti J. Shah
Contributing Editor
Russell A. Stamets
Contributing Editor
Richard Bistrong
Contributing Editor
Eric Carlson
Contributing Editor
Job Title: Deputy Chief Compliance Officer
Employer: Orthofix
Location: Lewisville, Texas USA
Description: The Deputy Chief Compliance Officer will be responsible for the development, enhancement and consistent implementation of the global compliance program and improving Orthofix’s internal controls and processes designed to detect and prevent acts of corruption and fraud.… Continue Reading
The SEC Wednesday charged Texas-based medical device maker Orthofix International with violating the Foreign Corrupt Practices Act when its subsidiary in Brazil made improper payments to doctors at government-owned hospitals to increase sales.… Continue Reading
Job Title: Corporate Compliance Manager
Employer: Orthofix Inc.
Location: Lewisville, Texas, United States
POSITION SUMMARY: The Corporate Compliance Manager will assist the Chief Compliance Officer (“CCO”) or the CCO’s designee in managing, developing and implementing various compliance initiatives for the BioStim strategic business unit (“SBU”) and other Orthofix SBUs.… Continue Reading
Job Title: Corporate Compliance Manager
Employer: Orthofix Inc.
Location: Lewisville, Texas USA
Description
The Corporate Compliance Manager will assist the Chief Compliance Officer (“CCO”) or the CCO’s designee in developing and implementing various domestic and international compliance initiatives, focusing primarily on policies and procedures and training and education, but also including auditing and monitoring, with the objective of facilitating and maintaining an effective Corporate Compliance Program and ensuring the company’s continued compliance with the domestic Corporate Integrity Agreement and the FCPA settlement.… Continue Reading
At the beginning of this year, China’s president Xi Jinping promised to fight both “tigers” and “flies” — high-ranking and low-ranking corrupt officials — in his crackdown on corruption. Since then, the anti-graft campaign has led to the conviction of Bo Xilai and to the front-page investigations of foreign companies in the pharmaceutical and oil and gas sectors, among others.… Continue Reading
Twelve companies settled FCPA enforcement actions in 2012 by paying a total of $259.4 million.… Continue Reading
During the quarter just ended, there were five corporate FCPA enforcement actions, one enforcement against an individual by the SEC, four criminal sentencings of individuals, and three and a half corporate declinations.… Continue Reading
Texas-based medical device company Orthofix International N.V. settled FCPA charges today relating to bribes in Mexico.
The company agreed to pay the SEC $5.2 million, including $4.98 million in disgorgement and $242,000 in prejudgment interest.… Continue Reading
